Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 177

The DOI matches its Crossref record.

Best Practice No 176: Updated recommendations for HER2 testing in the UK

Open access
Ellis, I O, Bartlett, J, Dowsett, M, Humphreys, S, Jasani, B, Miller, K, Pinder, S E, Rhodes, A, Walker, R · 2004 · Journal of Clinical Pathology

Abstract

This paper serves to update previously published guidance on rationale and methodology for HER2 laboratory testing following the recommendation for the use of HER2 targeted treatment in the management of advanced breast cancer in the UK. Emphasis is placed on the standardisation of methodology and assessment and strategies to achieve high quality performance. A two phase testing algorithm based on first line immunocytochemistry evaluation and second line fluorescence in situ hybridisation assessment of borderline cases is recommended. To ensure maintenance of expertise, an annual caseload volume of at least 250 cases is recommended for laboratories providing a testing service.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jcp.2003.007724

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 18

  1. 2002, Int J Clin Pract, 56, 261, 10.1111/j.1742-1241.2002.tb11253.x · doi:10.1111/j.1742-1241.2002.tb11253.x
  2. 10.1136/jcp.53.12.890 · doi:10.1136/jcp.53.12.890
  3. 1994, Cancer Res, 54, 2771
  4. 10.1054/brst.2000.0167 · DOI
  5. 10.1038/modpathol.3880288 · doi:10.1038/modpathol.3880288
  6. 10.1136/jcp.53.5.374 · DOI · Paper page
  7. 10.1309/AJ84-50AK-1X1B-1Q4C · DOI
  8. 2002, Crit Rev Oncol Hematol, 43, 231, 10.1016/S1040-8428(01)00207-4 · DOI
  9. 10.1093/jnci/94.11.852 · DOI · Paper page
  10. 10.1093/jnci/94.11.855 · DOI · Paper page
  11. 2001, J Pathol, 195, 5A
  12. 10.1309/4NCM-QJ9W-QM0J-6QJE · doi:10.1309/4ncm-qj9w-qm0j-6qje
  13. 10.1309/97WN-W6UX-XJWT-02H2 · DOI
  14. 2000, Semin Oncol, 27, 46
  15. 10.1385/MB:21:3:217 · doi:10.1385/mb:21:3:217
  16. 10.1002/path.971 · DOI · Paper page
  17. 10.1002/path.1354 · DOI
  18. 10.1054/cdip.2002.0155 · DOI

Cited by

See all 177

Metadata

Authors
Ellis, I. O., Bartlett, J., Dowsett, M., Humphreys, S., Jasani, B., Miller, K., Pinder, S. E., Rhodes, A., & Walker, R.
Venue
Journal of Clinical Pathology
Publisher
BMJ
Published
2004-02-27
Volume
57
Issue
3
Pages
233-237
ISSN
  • 0021-9746 (ISSN-L)
  • 1472-4146
OpenAlex
W2133573009
Cited by
177
References
0
FWCI
8.96
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Best Practice No 176: Updated recommendations for HER2 testing in the UK. https://app.cochat.ai/papers/10.1136/jcp.2003.007724
The paper
Ellis, I. O., Bartlett, J., Dowsett, M., Humphreys, S., Jasani, B., Miller, K., Pinder, S. E., Rhodes, A., & Walker, R. (2004). Best Practice No 176: Updated recommendations for HER2 testing in the UK. Journal of Clinical Pathology. https://doi.org/10.1136/jcp.2003.007724

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.